BioLineRx Ltd. ( BLRX) - Key Metrics
BLRX Revenue per Share metrics
| Date | Revenue per Share | Net Income per Share | Operating Cash Flow | Free Cash Flow per Share |
|---|---|---|---|---|
| 2026Q1 | ? | ? | ? | ? |
| 2025Q4 | ? | ? | ? | ? |
| 2025Q3 | $0 | $0 | $0 | $0 |
| 2025Q2 | $0 | $0 | $0 | $0 |
| 2025Q1 | $0 | $0 | $0 | $0 |
BLRX Payout ratio and Price per Earnings ratio
| Date | Payout ratio | PE ratio |
|---|---|---|
| 2026Q1 | ? | ? |
| 2025Q4 | ? | ? |
| 2025Q3 | ? | -4.21 |
| 2025Q2 | ? | -1.11 |
| 2025Q1 | ? | 0.44 |
BLRX
Price: $3.37
52 week price:
Exchange: NCM
Sector: Healthcare
Industry: Biotechnology
Country: Israel
Volume: 323100
Ebitda: -7.1 millionMarket Capitalization: 14.2 million